Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferationLinsheng Zhang, Alan D. Friedman|Blood|2007Cited by 66
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A. Alzubi, Alan D. Friedman|Cancer Immunology Immunotherapy|2025Cited by 1